Research Topics
| Solveig HofvindSummaryAffiliation: Cancer Registry of Norway Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer?Solveig Hofvind
Cancer Registry of Norway, Oslo, Norway
Acta Oncol 43:467-73. 2004..The process indicators achieved in the NBCSP are promising as regards future mortality reduction. The incidence of interval cancer 13-24 months after screening is higher than recommended in the European guidelines...
Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening programSolveig Hofvind
Cancer Registry of Norway, Montebello, N 0310 Oslo, Norway
Radiology 237:437-43. 2005..To retrospectively investigate whether different review designs have an influence on the estimate of missed interval cancer in a population-based breast cancer screening program...
Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programmeSolveig Hofvind
The Cancer Registry of Norway, Norway
J Med Screen 13:192-6. 2006....
The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening ProgramSolveig Hofvind
The Cancer Registry of Norway, Montebello, Oslo
Cancer 101:1501-7. 2004..A secondary objective was to estimate the cumulative risk of undergoing fine-needle aspiration cytology, core needle biopsy, and open biopsy with benign morphology in the same group of women...
[Incidence of breast cancer before and after implementation of mammography screening]Solveig Hofvind
Institutt for populasjonsbasert kreftforskning, Kreftregisteret, Montebello, 0310 Oslo
Tidsskr Nor Laegeforen 126:2935-8. 2006..Such an implementation is expected to give an initial increased incidence followed by a decrease. We here present general and stage-specific incidences of breast cancer by age groups, in the first 9 counties that implemented the NBCSP...
Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screensSolveig Hofvind
The Cancer Registry of Norway, Norway
Int J Cancer 118:3112-7. 2006..The increased risk of interval cancer, which may partly be due to decreased sensitivity of mammograms in HT users, remains a challenge in breast cancer screening programs...
Hormone therapy use and mammographic density in postmenopausal Norwegian womenElisabeth Couto
Department of Nutrition, University of Oslo, Oslo, Norway
Breast Cancer Res Treat 132:297-305. 2012..A higher mammographic density was found in EPT users compared to never HT users, particularly in women using high-dose NETA regimens. Age and BMI modified the association between EPT use and mammographic density...
Screening-detected breast cancers: discordant independent double reading in a population-based screening programSolveig Hofvind
Department of Screening based Research, Cancer Registry of Norway, Montebello, 0310 Oslo, Norway
Radiology 253:652-60. 2009..To analyze discordant and concordant screening-detected breast cancers in a nationwide population-based screening program by using independent double reading with consensus...
Using the European guidelines to evaluate the Norwegian Breast Cancer Screening ProgramSolveig Hofvind
Department of Screening based Research, The Cancer Registry of Norway, Montebello, Oslo, 0310, Norway
Eur J Epidemiol 22:447-55. 2007..Based on the results, we anticipate a future mortality reduction from breast cancer in women invited to the NBCSP...
Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programmeRagnhild Sørum
Cancer Registry of Norway, Department of Screening based Research, Box 5313 Majorstuen, N 0304 Oslo, Norway
Breast 19:499-505. 2010..The aim of this study was to investigate the incidence according to grade distribution, age, and implementation of a population-based screening programme...
Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?Solveig Hofvind
Cancer Registry of Norway, N 0310 Oslo, Norway
Int J Cancer 130:2930-8. 2012..Both factors likely contributed to the observed trends, and the role of each may vary across age groups...
Alcohol intake and mammographic density in postmenopausal Norwegian womenSamera Azeem Qureshi
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Breast Cancer Res Treat 131:993-1002. 2012..There was no effect modification by body mass index, age, or hormone therapy use. We found no evidence of an association between alcohol intake and percent mammographic density...
Comparing screening mammography for early breast cancer detection in Vermont and NorwaySolveig Hofvind
Department of Screening based Research, The Cancer Registry of Norway, Oslo, Norway
J Natl Cancer Inst 100:1082-91. 2008..We examined how these differences affect early detection of breast cancer by comparing performance measures and histopathologic outcomes in women undergoing opportunistic screening in Vermont and organized screening in Norway...
Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-programSolveig Hofvind
The Cancer Registry of Norway, Oslo, Norway
Acta Oncol 47:225-31. 2008..The screening period is divided into those invited versus those not invited to the screening program, and those exposed (participants) versus those not exposed to the program (non-participants)...
Mammographic density and intake of selected nutrients and vitamins in Norwegian womenSamera Azeem Qureshi
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Nutr Cancer 63:1011-20. 2011..This study provides some evidence of an association between MD and dietary intake. Our study highlights the importance of adequate adjustments for BMI in studies of diet and MD...
Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screeningSolveig Hofvind
Department of Screening based Research, Cancer Registry of Norway, Oslo, Norway
Acta Radiol 52:481-7. 2011..Ductal carcinoma in situ of the breast (DCIS) represents a challenge in mammographic screening due to its unknown progression into invasive cancer. The majority of the DCIS is detected due to signs of calcifications on the mammograms...
[Does organized mammographic screening reduce breast cancer mortality? The Cancer Registry's view on the current debate]Hege Wang
Tidsskr Nor Laegeforen 122:211-3. 2002
Second events following ductal carcinoma in situ of the breast: a register-based cohort studyRagnhild Sørum Falk
Department of Screening based Research, Cancer Registry of Norway, Box 5313, Oslo, Majorstuen N 0304, Norway
Breast Cancer Res Treat 129:929-38. 2011..Patients with DCIS have an increased risk of both subsequent breast malignancy and breast cancer death compared with women in the general population. Our results support previous knowledge of DCIS as a heterogeneous disease...
Comparing interval breast cancer rates in Norway and North Carolina: results and challengesSolveig Hofvind
Department of Screening based Research, The Cancer Registry of Norway, Oslo, Norway
J Med Screen 16:131-9. 2009..To compare interval breast cancer rates (ICR) between a biennial organized screening programme in Norway and annual opportunistic screening in North Carolina (NC) for different conceptualizations of interval cancer...
Breast cancer screening--prevalence of disease in women who only respond after an invitation reminderSolveig Hofvind
The Cancer Registry of Norway, Montebello, 0310 Oslo, Norway
J Med Screen 14:21-2. 2007..The risk of breast cancer is higher in women who respond only after a reminder letter, indicating that the value of sending a reminder should be assessed in the light of these results, as well as by the increase in the attendance rate...
Full-field digital mammography compared to screen film mammography in the prevalent round of a population-based screening programme: the Vestfold County StudyEinar Vigeland
Department of Radiology, Vestfold Hospital, Halfdan Wilhelmsens Alle 17, 3116 Tønsberg, Norway
Eur Radiol 18:183-91. 2008..In conclusion FFDM had a significantly higher detection rate for DCIS than SFM. For invasive cancers no difference was seen. FFDM also had a significantly higher PPV and a significantly lower technical recall rate...
Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmesSven Törnberg
Cancer Screening Unit, Oncologic Centre, Karolinska University Hospital, S 171 76, Stockholm, Sweden
Acta Oncol 45:528-35. 2006..The study showed that the population-based breast cancer mortality trend is too crude a measure to detect the effect of screening on breast cancer mortality during the first years after the start of a programme...
[Introduction and evaluation of screening]Solveig Hofvind
Tidsskr Nor Laegeforen 123:971. 2003
Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II studyPer Skaane
Department of Radiology, Ullevaal University Hospital, University of Oslo, Kirkeveien 166, NO 0407 Oslo, Norway
Radiology 244:708-17. 2007..To prospectively compare performance indicators at screen-film mammography (SFM) and full-field digital mammography (FFDM) in a population-based screening program...
